InflaRx NV (IFRX)
2.04
-0.06
(-2.86%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
InflaRx Price : 2.04 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 2.03 | 2.12 | 2.025 | 2.10 | 419898.0 |
| Aug 20, 2026 | 2.12 | 2.15 | 2.005 | 2.02 | 587737.0 |
| Aug 19, 2026 | 2.18 | 2.22 | 2.09 | 2.12 | 958323.0 |
| Aug 18, 2026 | 2.05 | 2.18 | 2.035 | 2.18 | 556583.0 |
| Aug 17, 2026 | 2.04 | 2.095 | 2.03 | 2.07 | 564831.0 |
| Aug 14, 2026 | 2.01 | 2.05 | 1.92 | 2.04 | 1.468M |
| Aug 13, 2026 | 2.02 | 2.055 | 1.965 | 2.01 | 1.899M |
| Aug 12, 2026 | 1.99 | 2.06 | 1.93 | 2.01 | 1.570M |
| Aug 11, 2026 | 1.99 | 2.02 | 1.92 | 2.00 | 491391.0 |
| Aug 10, 2026 | 1.86 | 1.97 | 1.81 | 1.96 | 900604.0 |
| Aug 07, 2026 | 1.81 | 1.905 | 1.78 | 1.84 | 1.167M |
| Aug 06, 2026 | 1.77 | 1.86 | 1.709 | 1.72 | 538685.0 |
| Aug 05, 2026 | 1.76 | 1.81 | 1.745 | 1.77 | 710045.0 |
| Aug 04, 2026 | 1.79 | 1.878 | 1.72 | 1.78 | 888716.0 |
| Aug 03, 2026 | 1.68 | 1.76 | 1.675 | 1.75 | 557848.0 |
| Jul 31, 2026 | 1.76 | 1.76 | 1.64 | 1.70 | 583925.0 |
| Jul 30, 2026 | 1.68 | 1.735 | 1.65 | 1.72 | 1.114M |
| Jul 29, 2026 | 1.69 | 1.761 | 1.64 | 1.65 | 907013.0 |
| Jul 28, 2026 | 1.73 | 1.75 | 1.625 | 1.69 | 1.201M |
| Jul 27, 2026 | 1.75 | 1.80 | 1.68 | 1.70 | 928391.0 |
| Jul 24, 2026 | 1.76 | 1.793 | 1.70 | 1.74 | 823298.0 |
| Jul 23, 2026 | 1.79 | 1.825 | 1.72 | 1.73 | 549261.0 |
| Jul 22, 2026 | 1.85 | 1.86 | 1.76 | 1.80 | 917926.0 |
| Jul 21, 2026 | 1.85 | 1.865 | 1.77 | 1.81 | 1.032M |
| Jul 20, 2026 | 1.92 | 2.07 | 1.81 | 1.82 | 882944.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 112.82 |
| Immatics NV | 8.70 |
| Beam Therapeutics, Inc. | 28.34 |
| Kymera Therapeutics, Inc. | 121.01 |
Price Related Metrics
| PS Ratio | 2289.38 |
| Price to Book Value | 1.799 |
| Earnings Yield | -31.78% |
| Market Cap | 300.63M |